Skip to main content
. 2022 Mar 28;13(6):1985–2000. doi: 10.7150/jca.69544

Figure 7.

Figure 7

(A) Flow cytometry showing the percentages of AGS cells transfected with ASF1b-si/NC or vector/ASF1b-OE at different cell cycle phases. (B) Flow cytometry showing the percentages of MGC803 cells transfected with ASF1b-si/NC or vector/ASF1b-OE at different cell cycle phases.